Joe Baxter

Joe Baxter is a Senior Analyst in the Opportunity Assessment Group at LifeArc, focusing on detailed scientific, competition, and IP diligence to support strategic decisions with an emphasis on Childhood Cancer Translational Challenge. Prior experience includes roles as Scientist III and Scientist II at Engitix Therapeutics, where contributions included target identification and validation for inflammatory bowel disease and pancreatic ductal adenocarcinoma. Joe Baxter's academic background encompasses a PhD in Functional Genetic Epidemiology from The Institute of Cancer Research and a BA in Natural Sciences from the University of Cambridge, along with earlier research roles highlighting expertise in gene regulation and cancer treatment.